Core Viewpoint - GoHealth, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a False Claims Act complaint filed by the U.S. Department of Justice against several health insurance companies, including GoHealth [1][2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth on behalf of its stockholders [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, GoHealth and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ's lawsuit, GoHealth's stock price dropped by $1.09 per share, representing a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2].

Core Viewpoint - SelectQuote's share price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage market [1][3]. Group 1: Lawsuit and Allegations - The U.S. Department of Justice filed a lawsuit against SelectQuote and other insurance brokers, claiming they violated the False Claims Act [1]. - The investigation focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. - Allegations include that SelectQuote directed Medicare beneficiaries to plans that provided the highest kickbacks to brokers, rather than acting in the best interest of the beneficiaries [5]. Group 2: Financial Impact - Following the announcement of the lawsuit, SelectQuote's shares fell by over 19% on May 1, 2025 [1][3]. - The lawsuit raises concerns about the potential inflation of SelectQuote's financial results due to alleged steering practices [4]. Group 3: Whistleblower Information - Whistleblowers with non-public information regarding SelectQuote are encouraged to assist in the investigation, with potential rewards of up to 30% of any successful recovery made by the SEC [4].

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1] - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [3] - Following the DOJ's lawsuit announcement, GoHealth's stock price dropped by $1.09 per share, a decrease of 10.35%, closing at $9.44 per share on May 1, 2025 [3]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Regeneron Pharmaceuticals, Inc. regarding a class action lawsuit alleging misleading statements and omissions related to the company's pricing practices for its product Eylea during the class period from November 2, 2023, to October 30, 2024 [1]. Summary by Sections Allegations - The complaint alleges that Regeneron made materially false and misleading statements by failing to disclose payments made to distributors to subsidize credit card fees for Eylea customers [1] - These undisclosed payments led to a price concession that lowered Eylea's selling price, providing a competitive advantage in a sensitive pricing environment for retina practices [1] - As a result, Regeneron allegedly overstated Eylea sales and misrepresented its business operations and prospects, violating the False Claims Act by not reporting these payments as price concessions [1] Class Action Details - Shareholders who purchased shares of REGN during the specified class period are encouraged to register for the class action, with a deadline set for March 10, 2025 [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case, and there is no cost or obligation to participate [2] Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]